Molecular glue-focused biotech f5…
Molecular glue-focused biotech f5 Therapeutics has failed to stick around [...]
Molecular glue-focused biotech f5 Therapeutics has failed to stick around [...]
Pharmas’ direct drug sale platforms could be the key to [...]
The FDA has resumed review of Capricor Therapeutics’ previously rejected [...]
The FDA’s newest draft guidance reinforces its previous commitment to [...]
With sales booming at Eli Lilly, the Indianapolis company has [...]
Spruce Biosciences has named Dale Hooks as chief commercial officer, [...]
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 [...]
Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out [...]
Shanghai-based Tenacia Biotechnology is making a $308 million biobucks move [...]
After a tumultuous tenure marked by recent clashes with the [...]